Bupropion for the treatment of neuropathic pain

American Journal of Hospice and Palliative Medicine

Volumn 27, Issue 5, 2010, Pages 333-336

  Shah, Tanmay H ^a   Moradimehr, Abdolali ^b  

^a East Tennessee State University   (United States)

^b University of Appalachia College of Pharmacy   (United States)

Author keywords

bupropion; chronic pain; neuropathic pain; tricyclic antidepressant

Indexed keywords

AMFEBUTAMONE; ANALGESIC AGENT; DOPAMINE UPTAKE INHIBITOR; NEUROTRANSMITTER UPTAKE INHIBITOR;

CHRONIC DISEASE; CONTROLLED CLINICAL TRIAL (TOPIC); HUMAN; METHODOLOGY; NEURALGIA; PAIN; PALLIATIVE THERAPY; REVIEW; TREATMENT OUTCOME;

ANALGESICS, NON-NARCOTIC; BUPROPION; CHRONIC DISEASE; CONTROLLED CLINICAL TRIALS AS TOPIC; DOPAMINE UPTAKE INHIBITORS; HUMANS; NEURALGIA; NEUROTRANSMITTER UPTAKE INHIBITORS; PAIN; PALLIATIVE CARE; TREATMENT OUTCOME;

EID: 77955329480     PISSN: 10499091     EISSN: None     Source Type: Journal    
DOI: 10.1177/1049909110361229     Document Type: Review

References (43)

1. Stacey BR Management of peripheral neuropathic pain. Am J Phys Med Rehabil. 2005;84(3 suppl):S4-S16.
2. Finnerup NB A review of central neuropathic pain states. Curr Opin Anaesthesiol. 2008;21(5):586-589.
3. Sindrup SH, Otto M., Finnerup NB, Jensen TS Antidepressants in the treatment of neuropathic pain. Basic Clin Pharmacol Toxicol. 2005;96(6):399-409.
4. Maizels M., McCarberg B. Antidepressants and antiepileptic drugs for chronic non-cancer pain. Am Fam Physician. 2005;71(3): 483-490.
5. Tölle T., Dukes E., Sadosky A. Patient burden of trigeminal neuralgia: results from a cross-sectional survey of health state impairment and treatment patterns in six European countries. Pain Pract. 2006; 6(3):153-160.
6. Matsuzawa-Yanagida K., Narita M., Nakajima M.,et al.Usefulness of antidepressants for improving the neuropathic pain-like state and pain-induced anxiety through actions at different brain sites. Neuropsychopharmacology. 2008;33(8):1952-1965.
7. Xu H., Wu LJ, Wang H.,et al.Presynaptic and postsynaptic amplifications of neuropathic pain in the anterior cingulate cortex. J Neurosci. 2008;28(29):7445-7453.
8. Aurilio C., Pota V., Pace MC, Passavanti MB, Barbarisi M. Ionic channels and neuropathic pain: physiopathology and applications. J Cell Physiol. 2008;215(1):8-14.
9. Backonja MM, Irving G., Argoff C. Rational multidrug therapy in the treatment of neuropathic pain. Curr Pain Headache Rep. 2006;10(1):34-38.
10. New PW, Lim TC, Hill ST, Brown DJ A survey of pain during rehabilitation after acute spinal cord injury. Spinal Cord. 1997; 35(10):658-663.
11. Linley JE, Rose K., Patil M., Robertson B., Akopian AN, Gamper N. Inhibition of Mcurrent in sensory neurons by exogenous proteases: a signaling pathway mediating inflammatory nociception. J Neurosci. 2008;28(44):11240-11249.
12. Muth-Selbach US, Tegeder I., Brune K., Geisslinger G. Acetaminophen inhibits spinal prostaglandin E2 release after peripheral noxious stimulation. Anesthesiology. 1999;91(1):231-239.
13. Moulin DE, Clark AJ, Gilron I.,et al,Canadian Pain Society. Pharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain Society. Pain Res Manag. 2007;12(1):13-21.
14. Dobecki DA, Schocket SM, Wallace MS Update on pharmacotherapy guidelines for the treatment of neuropathic pain. Curr Pain Headache Rep. 2006;10(3):185-190.
15. Vrethem M., Boivie J., Arnqvist H., Holmgren H., Lindström T., Thorell LH A comparison a amitriptyline and maprotiline in the treatment of painful polyneuropathy in diabetics and nondiabetics. Clin J Pain. 1997;13(4):313-323.
16. Jones KL, Finn DP, Governo RJ,et al.Identification of discrete sites of action of chronic treatment with desipramine in a model of neuropathic pain. Neuropharmacology. 2009;56(2):405-413.
17. Sindrup SH, Gram LF, Skjold T., Grodum E., Brøsen K., Beck-Nielsen H. Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms. A double-blind cross-over study. Br J Clin Pharmacol. 1990;30(5):683-691.
18. Rowbotham MC, Goli V., Kunz NR, Lei D. Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study. Pain. 2004;110(3):697-706.
19. Fishbain D., Berman K., Kajdasz DK Duloxetine for neuropathic pain based on recent clinical trials. Curr Pain Headache Rep. 2006; 10(3):199-204.
20. Sindrup SH, Gram LF, Brøsen K., Eshøj O., Mogensen EF The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain. 1990;42(2): 135-144.
21. Sindrup SH, Bjerre U., Dejgaard A., Brøsen K., Aaes-Jørgensen T., Gram LF The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy. Clin Pharmacol Ther. 1992;52(5):547-552.
22. Max MB, Culnane M., Schafer SC,et al.Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology. 1987;37(4):589-596.
23. Max MB, Schafer SC, Culnane M., Smoller B., Dubner R., Gracely RH Amitriptyline, but not lorazepam, relieves postherpetic neuralgia. Neurology. 1988;38(9):1427-1432.
24. Ray WA, Meredith S., Thapa PB, Hall K., Murray KT Cyclic antidepressants and the risk of sudden cardiac death. Clin Pharmacol Ther. 2004;75(3):234-241.
25. Finnerup NB, Otto M., McQuay HJ, Jensen TS, Sindrup SH Algorithm for neuropathic pain treatment: an evidence based proposal. Pain. 2005;118(3):289-305.
26. Wernicke JF, Pritchett YL, D'Souza DN,et al.A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain. Neurology. 2006;67(8):1411-1420.
27. Smith T., Nicholson RA Review of duloxetine in the management of diabetic peripheral neuropathic pain. Vasc Health Risk Manag. 2007;3(6):833-844.
28. Otto M., Bach FW, Jensen TS, Brøsen K., Sindrup SH Escitalopram in painful polyneuropathy: a randomized, placebo-controlled, cross-over trial. Pain. 2008;139(2):275-283.
29. Ross EL The evolving role of antiepileptic drugs in treating neuropathic pain. Neurology. 2000;55(5 suppl 1):S41-S46.
30. Sills GJ The mechanisms of action of gabapentin and pregabalin. Curr Opin Pharmacol. 2006;6(1):108-113.
31. Hayashida K., Eisenach JC Multiplicative interactions to enhance gabapentin to treat neuropathic pain. Eur J Pharmacol. 2008; 598(1-3):21-26.
32. Freynhagen R., Strojek K., Griesing T., Whalen E., Balkenohl M. Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens. Pain. 2005;115(3):254-263.
33. Arezzo JC, Rosenstock J., Lamoreaux L., Pauer L. Efficacy and safety of pregabalin 600 mg/d for treating painful diabetic peripheral neuropathy: a double-blind placebo-controlled trial. BMC Neurol. 2008;8(8):33.
34. Gilron I., Bailey JM, Tu D., Holden RR, Weaver DF, Houlden RL Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med. 2005;352(13):1324-1334.
35. Eisenberg E., McNicol ED, Carr DB Efficacy of mu-opioid agonists in the treatment of evoked neuropathic pain: Systematic review of randomized controlled trials. Eur J Pain. 2006;10(8): 667-676.
36. Berrios I., Castro C., Kuffler DP Morphine: axon regeneration, neuroprotection, neurotoxicity, tolerance, and neuropathic pain. P R Health Sci J. 2008;27(2):119-128.
37. Mannino R., Coyne P., Swainey C., Hansen LA, Lyckholm L. Methadone for cancer-related neuropathic pain: a review of the literature. J Opioid Manag. 2006;2(5):269-276.
38. Simmons Z., Feldman EL Update on diabetic neuropathy. Curr Opin Neurol. 2002;15(5):595-603.
39. Dhillon S., Yang LP, Curran MP Bupropion: a review of its use in the management of major depressive disorder. Drugs. 2008;68(5): 653-689.
40. Jefferson JW Bupropion extended-release for depressive disorders. Expert Rev of Neurotherapeutics. 2008;8(5):715-22.
41. Katz J., Pennella-Vaughan J., Hetzel RD, Kanazi GE, Dworkin RH A randomized, placebo-controlled trial of bupropion sustained release in chronic low back pain. J Pain. 2005;6(10):656-661.
42. Semenchuk MR, Davis B. Efficacy of sustained-release bupropion in neuropathic pain: an open-label study. Clin J Pain. 2000;16(1):6-11.
43. Semenchuk MR, Sherman S., Davis B. Double-blind, randomized trial of bupropion SR for the treatment of neuropathic pain. Neurology. 2001;57(9):1583-1588.